Oncotarget

Keyphrases

Publications

volume 15, 2024

Alberto Moscona-Nissan, Karl J Habashy, Victor A Arrieta, Adam M Sonabend, Crismita Dmello
Combining causal and correlative approaches to discover biomarkers of response to paclitaxel. Oncotarget 15 (2024)
Mark Lee, Luc Gt Morris
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation. Oncotarget 15 (2024)
Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo
BCAS1 defines a heterogeneous cell population in diffuse gliomas. Oncotarget 15 (2024)
Michael R Booth, Laurence Booth, Jane L Roberts, Cameron West, Paul Dent
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget 15 (2024)
Mathew Lozinski, Nikola A Bowden, Moira C Graves, Michael Fay, Bryan W Day, Brett W Stringer, Paul A Tooney
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. Oncotarget 15 (2024)
Wei Zhang, Arndt A Schmitz, Roosa E Kallionpää, Merja Perälä, Niina Pitkänen, Mikko Tukiainen, Erika Alanne, Korinna Jöhrens, Renate Schulze-Rath, Bahman Farahmand, Jihong Zong
Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland. Oncotarget 15 (2024)
Mark Lee, Luc Gt Morris
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation. Oncotarget 15 (2024)
Mark Lee, Luc Gt Morris
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation. Oncotarget 15 (2024)
Sijie Cheng, Tieling Li, Cheng Wang, Keyu Wang, Chengcai Lai, Jin Yan, Hongxia Fan, Fang Sun, Zhaohai Wang, Peirui Zhang, Linxiang Yu, Zhixian Hong, Guanglin Lei, Baijun Sun, Yuan Gao, Zhaohui Xiao, Xu Ji, Ruilan Wang, Jianzhong Wu, Xiliang Wang, Shaogeng Zhang, Penghui Yang
Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma. Oncotarget 15 (2024)
Mathew Lozinski, Nikola A Bowden, Moira C Graves, Michael Fay, Bryan W Day, Brett W Stringer, Paul A Tooney
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. Oncotarget 15 (2024)
Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma. Oncotarget 15 (2024)
Sijie Cheng, Tieling Li, Cheng Wang, Keyu Wang, Chengcai Lai, Jin Yan, Hongxia Fan, Fang Sun, Zhaohai Wang, Peirui Zhang, Linxiang Yu, Zhixian Hong, Guanglin Lei, Baijun Sun, Yuan Gao, Zhaohui Xiao, Xu Ji, Ruilan Wang, Jianzhong Wu, Xiliang Wang, Shaogeng Zhang, Penghui Yang
Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma. Oncotarget 15 (2024)
Changhwan Yoon, Kevin K Chang, Jun Ho Lee, William D Tap, Charles P Hart, M Celeste Simon, Sam S Yoon
Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy. Oncotarget 15 (2024)
P A Shatalov, N A Falaleeva, E A Bykova, D O Korostin, V A Belova, A A Zabolotneva, A P Shinkarkina, A Yu Gorbachev, M B Potievskiy, V S Surkova, Zh V Khailova, N A Kulemin, Denis Baranovskii, A A Kostin, A D Kaprin, P V Shegai
Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis. Oncotarget 15 (2024)
Wei Zhang, Arndt A Schmitz, Roosa E Kallionpää, Merja Perälä, Niina Pitkänen, Mikko Tukiainen, Erika Alanne, Korinna Jöhrens, Renate Schulze-Rath, Bahman Farahmand, Jihong Zong
Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland. Oncotarget 15 (2024)
Ashley Del Dosso, Elizabeth Tadevosyan, James R Berenson
Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma. Oncotarget 15 (2024)
Ashley Del Dosso, Elizabeth Tadevosyan, James R Berenson
Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma. Oncotarget 15 (2024)
Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo
BCAS1 defines a heterogeneous cell population in diffuse gliomas. Oncotarget 15 (2024)
Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan
Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Oncotarget 15 (2024)
Shreya Bhatia, Manuel G Cortez, Spencer Lessans, Wade T Iams
Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report. Oncotarget 15 (2024)
Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo
BCAS1 defines a heterogeneous cell population in diffuse gliomas. Oncotarget 15 (2024)
Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma. Oncotarget 15 (2024)
Uzma Saqib, Isaac S Demaree, Alexander G Obukhov, Mirza S Baig, Amiram Ariel, Krishnan Hajela
The fate of drug discovery in academia; dumping in the publication landfill? Oncotarget 15 (2024)
Sijie Cheng, Tieling Li, Cheng Wang, Keyu Wang, Chengcai Lai, Jin Yan, Hongxia Fan, Fang Sun, Zhaohai Wang, Peirui Zhang, Linxiang Yu, Zhixian Hong, Guanglin Lei, Baijun Sun, Yuan Gao, Zhaohui Xiao, Xu Ji, Ruilan Wang, Jianzhong Wu, Xiliang Wang, Shaogeng Zhang, Penghui Yang
Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma. Oncotarget 15 (2024)
Shreya Bhatia, Manuel G Cortez, Spencer Lessans, Wade T Iams
Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report. Oncotarget 15 (2024)
Ashley Del Dosso, Elizabeth Tadevosyan, James R Berenson
Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma. Oncotarget 15 (2024)
Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma. Oncotarget 15 (2024)
Michael R Booth, Laurence Booth, Jane L Roberts, Cameron West, Paul Dent
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget 15 (2024)
Alberto Moscona-Nissan, Karl J Habashy, Victor A Arrieta, Adam M Sonabend, Crismita Dmello
Combining causal and correlative approaches to discover biomarkers of response to paclitaxel. Oncotarget 15 (2024)
P A Shatalov, N A Falaleeva, E A Bykova, D O Korostin, V A Belova, A A Zabolotneva, A P Shinkarkina, A Yu Gorbachev, M B Potievskiy, V S Surkova, Zh V Khailova, N A Kulemin, Denis Baranovskii, A A Kostin, A D Kaprin, P V Shegai
Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis. Oncotarget 15 (2024)
Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan
Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Oncotarget 15 (2024)
Huan Liu, Guizhi Zhou, Xin Fu, Haiyan Cui, Guangrui Pu, Yao Xiao, Wei Sun, Xinhua Dong, Libin Zhang, Sijia Cao, Guiqin Li, Xiaowei Wu, Xu Yang
Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget 15 (2024)
Changhwan Yoon, Kevin K Chang, Jun Ho Lee, William D Tap, Charles P Hart, M Celeste Simon, Sam S Yoon
Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy. Oncotarget 15 (2024)
Wei Zhang, Arndt A Schmitz, Roosa E Kallionpää, Merja Perälä, Niina Pitkänen, Mikko Tukiainen, Erika Alanne, Korinna Jöhrens, Renate Schulze-Rath, Bahman Farahmand, Jihong Zong
Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland. Oncotarget 15 (2024)
Huan Liu, Guizhi Zhou, Xin Fu, Haiyan Cui, Guangrui Pu, Yao Xiao, Wei Sun, Xinhua Dong, Libin Zhang, Sijia Cao, Guiqin Li, Xiaowei Wu, Xu Yang
Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget 15 (2024)
P A Shatalov, N A Falaleeva, E A Bykova, D O Korostin, V A Belova, A A Zabolotneva, A P Shinkarkina, A Yu Gorbachev, M B Potievskiy, V S Surkova, Zh V Khailova, N A Kulemin, Denis Baranovskii, A A Kostin, A D Kaprin, P V Shegai
Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis. Oncotarget 15 (2024)
Fariba Poosti, Ruchi Bansal, Saleh Yazdani, Jai Prakash, Leonie Beljaars, Jacob van den Born, Martin H de Borst, Harry van Goor, Jan-Luuk Hillebrands, Klaas Poelstra
Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. Oncotarget 15 (2024)
Michael R Booth, Laurence Booth, Jane L Roberts, Cameron West, Paul Dent
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget 15 (2024)
Uzma Saqib, Isaac S Demaree, Alexander G Obukhov, Mirza S Baig, Amiram Ariel, Krishnan Hajela
The fate of drug discovery in academia; dumping in the publication landfill? Oncotarget 15 (2024)
Fariba Poosti, Ruchi Bansal, Saleh Yazdani, Jai Prakash, Leonie Beljaars, Jacob van den Born, Martin H de Borst, Harry van Goor, Jan-Luuk Hillebrands, Klaas Poelstra
Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. Oncotarget 15 (2024)
Fariba Poosti, Ruchi Bansal, Saleh Yazdani, Jai Prakash, Leonie Beljaars, Jacob van den Born, Martin H de Borst, Harry van Goor, Jan-Luuk Hillebrands, Klaas Poelstra
Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. Oncotarget 15 (2024)
Huan Liu, Guizhi Zhou, Xin Fu, Haiyan Cui, Guangrui Pu, Yao Xiao, Wei Sun, Xinhua Dong, Libin Zhang, Sijia Cao, Guiqin Li, Xiaowei Wu, Xu Yang
Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget 15 (2024)
Mark Lee, Luc Gt Morris
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation. Oncotarget 15 (2024)
Fariba Poosti, Ruchi Bansal, Saleh Yazdani, Jai Prakash, Leonie Beljaars, Jacob van den Born, Martin H de Borst, Harry van Goor, Jan-Luuk Hillebrands, Klaas Poelstra
Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. Oncotarget 15 (2024)
Alberto Moscona-Nissan, Karl J Habashy, Victor A Arrieta, Adam M Sonabend, Crismita Dmello
Combining causal and correlative approaches to discover biomarkers of response to paclitaxel. Oncotarget 15 (2024)
Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan
Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Oncotarget 15 (2024)
Uzma Saqib, Isaac S Demaree, Alexander G Obukhov, Mirza S Baig, Amiram Ariel, Krishnan Hajela
The fate of drug discovery in academia; dumping in the publication landfill? Oncotarget 15 (2024)
Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma. Oncotarget 15 (2024)
Mathew Lozinski, Nikola A Bowden, Moira C Graves, Michael Fay, Bryan W Day, Brett W Stringer, Paul A Tooney
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. Oncotarget 15 (2024)
Shreya Bhatia, Manuel G Cortez, Spencer Lessans, Wade T Iams
Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report. Oncotarget 15 (2024)